EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of the C3a‐C3aR Pathway in Diseases: Latest Research Advances

Xiangwei Bo iD, Mi Wang iD, Yang Liu iD, Yong Zhong iD

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/1754881 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mediators of Inflammation, online erschienen am 17.04.2026. Verfasst von Xiangwei Bo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Medicine, Affiliated Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210002, China, nju.edu.cn. Hauptthemen laut MEDLINE: Receptors, Complement, Complement C3a. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Province Key Project for Cadre Healthcare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C3a is a key active factor in the complement system, capable of participating in various physiological and pathological processes by binding to its C3a receptor (C3aR). The C3a‐C3aR pathway not only plays an important role in immune regulation but is also closely related to the occurrence and development of various inflammatory diseases, cardiovascular diseases, autoimmune diseases, and tumors. In recent years, research on the specific mechanisms of action of C3a‐C3aR in different diseases has gradually deepened. This article aims to review the basic functions of the C3a‐C3aR pathway, with a focus on summarizing the latest research advances in kidney diseases, cardiovascular diseases, neurodegenerative diseases, autoimmune diseases, and tumors, and to explore its prospects as a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, ComplementComplement C3aHumansAnimalsAutoimmune DiseasesKidney DiseasesNeoplasmsCardiovascular DiseasesNeurodegenerative DiseasesInflammationSignal Transduction

Stichwörter der Autor:innen

C3a-C3aR pathwayautoimmune diseasescancercardiovascular diseasesinflammationkidney diseasesneurodegenerative diseasestherapeutic target

Substanzen

Receptors, ComplementComplement C3acomplement C3a receptor

Autor:innen und Institutionen

  • Department of Health Medicine, Affiliated Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210002, China, nju.edu.cn.
  • Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao, Nanjing, 210009, China, seu.edu.cn.
  • Department of Critical Care Medicine, Affiliated Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210002, China, nju.edu.cn.

ORCID-Profile: Xiangwei Bo, Mi Wang, Yang Liu, Yong Zhong

Förderung

  • Jiangsu Province Key Project for Cadre Healthcare

Zitieren

APA

Bo, X., Wang, M., Liu, Y., & Zhong, Y. (2026). The Role of the C3a‐C3aR Pathway in Diseases: Latest Research Advances. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/1754881

Vancouver

Bo X, Wang M, Liu Y, Zhong Y. The Role of the C3a‐C3aR Pathway in Diseases: Latest Research Advances. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/1754881

BibTeX
@article{Bo2026,
  author = {Bo, Xiangwei and Wang, Mi and Liu, Yang and Zhong, Yong},
  title = {The Role of the C3a‐C3aR Pathway in Diseases: Latest Research Advances},
  journal = {Mediators of Inflammation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/mi/1754881}
}
Kostenlos starten →